Skip to main content

Find Clinical Trials

Home
Conditions
the Relationship Between Procalcitonin and 30-day Mortality in COVID Patients

Clinical trial condition

the Relationship Between Procalcitonin and 30-day Mortality in COVID Patients

Explore clinical trials studying the Relationship Between Procalcitonin and 30-day Mortality in COVID Patients. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

the Relationship Between Procalcitonin and 30-day Mortality in COVID Patients trial results

Completed

Procalcitonin Level and the High Risk of Mortality in 30 Days in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patient , Cases Series.

NCT05008016

Conditions: the Relationship Between Procalcitonin and 30-day Mortality in COVID Patients
Locations: younes Oujidi Berkane, Morocco

View Trial Details